Overview

Evidence supports an active role for atopic dermatitis patients in managing healthcare decisions based on an informed understanding of risks and benefits. In this activity, video vignettes provide learners with effective communication examples and shared decision-making strategies, providing examples of effective and efficient patient/provider discussions, resulting in better patient outcomes. 

This activity is jointly provided by Global Education Group and FACTORx in partnership with National Eczema Association. 

Learning Objectives

  • Describe the rationale and benefits for SDM in the care of patients with AD
  • Identify strategies for implementing SDM with AD patients
  • Express how implementing SDM with AD patients can lead to improved patient outcomes
  • Describe how to encourage patients to enroll in the National Eczema Association website and platform 

Faculty

 

Lawrence F. Eichenfield, MD

Professor of Dermatology and Pediatrics
Vice Chair, Department of Dermatology
Chief, Pediatric and Adolescent Dermatology
University of California, San Diego School of Medicine
San Diego, CA 

Jonathan Spergel, MD, PhD

Professor of Pediatrics
Perelman School of Medicine at University of Pennsylvania
Chief, Allergy Section
The Children’s Hospital of Philadelphia
Philadelphia, PA 

Jennifer LeBovidge, PhD

Psychologist, Atopic Dermatitis Center and Food Allergy Program
Boston Children's Hospital
Assistant Professor of Psychology
Harvard Medical School
Boston, MA

Peter Lio, MD

Clinical Assistant Professor of Dermatology & Pediatrics
Northwestern University Feinberg School of Medicine
Physician
Medical Dermatology Associates of Chicago
Chicago, IL 

Paul Doghramji, MD, FAAFP

Senior Family Physician
Collegeville Family Practice
Medical Director
Ursinus College
Collegeville, PA 

Maysel Kemp White, PhD

Founder
Healthcare Quality and Communication Improvement, LLC
Clearwater Beach, FL 

Alexis Smith

Patient

Raelle Brown

Patient

Disclosures

The following financial relationships have been disclosed by faculty.

Lawrence F. Eichenfield, MD

Advisory Board for Ortho Dermatologics. Consultant for Amgen Inc.; Dermavant Sciences, Inc.; Dermira, Inc.; DS Biopharma Limited; FORTÉ PHARMA; Galderma Laboratories, L.P.; Incyte Corporation; LEO Pharma Inc.; Lilly USA, LLC; Manio Therapeutics; MatriSys Bioscience; Medimetriks Pharmaceuticals, Inc.; Novan, Inc.; Novartis Pharmaceuticals Corporation; Ortho Dermatologics; Otsuka America Pharmaceutical, Inc.; Pfizer Inc.; Sanofi US and Regeneron Pharmaceuticals; and TopMD. Contracted Research for LEO Pharma Inc. and Sanofi US and Regeneron Pharmaceuticals. Services Provided for Promotional Purposes (Not for CME/CE Services) for Glenmark Pharmaceuticals.

Jonathan Spergel, MD, PhD

Advisory Board for Genentech; Regeneron Pharmaceuticals, Inc.; Takeda Pharmaceuticals U.S.A., Inc. Services Provided for Promotional Purposes (Not for CME/CE Services) for UpToDate, Inc.

Jennifer LeBovidge, PhD

Contracted Research for Pfizer Inc.

Peter Lio, MD

Consultant for AbbVie Inc.; AOBiome; Galderma Laboratories, L.P.; Johnson & Johnson; Kiniksa Pharmaceuticals, Ltd.; La Roche-Posay; L’ORÉAL PARIS; Menlo Therapeutics; Pfizer Inc.; Pierre Fabre Group; Regeneron Pharmaceuticals, Inc.; Sanofi US; and Valeant Pharmaceuticals. Contracted Research for AOBiome. Speaker’s Bureau for La Roche-Posay; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; and Sanofi US.

Paul Doghramji, MD, FAAFP

No financial relationships to disclose.

Maysel Kemp White, PhD, MFT, FAACH

No financial relationships to disclose.

Alexis Smith

No financial relationships to disclose.

Stephen Gawron

No financial relationships to disclose.

Raelle Brown

No financial relationships to disclose.

Ashley Marostica, RN, MSN

No financial relationships to disclose.

Kristin Delisi, NP

No financial relationships to disclose.

Lindsay Borvansky

No financial relationships to disclose.

Andrea Funk

No financial relationships to disclose.

Liddy Knight

No financial relationships to disclose.

Ashley Cann

No financial relationships to disclose.

Dan Duch, PhD

No financial relationships to disclose.

 

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.

CME/CE Information

AMA PRA Category 1 Credits

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and FACTORx. Global is accredited by the ACCME to provide continuing medical education for physicians. 


Designation Statement

Global Education Group designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

AANP

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and FACTORx. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024. This activity is approved for 1.00 contact hour which includes 0.30 hour of pharmacology. Activity ID #2702E. This activity was planned in accordance with AANP CE Standards and Policies. 


Designation Statement

This educational activity for 1.00 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Obtaining Credit

Once you have completed the activity, please click the "next" button to advance to the post-activity assessment. To complete this activity and claim credit, you must answer 4 out of the 5 questions correctly. If you are not successful after your first attempt, you will be given an opportunity to reflect upon the answer rationales and have the opportunity to review the educational content before proceeding. Once you have selected your answers, click the "submit" button to complete the evaluation questions and proceed to the claim credit screen.

Commercial Supporter

This activity is supported by an educational grant provided by Pfizer, Inc.

Education Partner

FACTORx


Patient Resource


Fine Print

Internet Explorer (version 9.0 and above) is the minimum supported browser for Pri-Med Online eCME activities. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection (DSL, cable modem, or LAN-based) is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.